⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
TLRY
IGC
JNJ
LLY
BMY
GSK
PFE
ABBV
Saudi Arabia Baby Healthcare Products Market Size, Share, Trends, and Forecast 2025-2034 | Premium Demand and E-Commerce Drive Growth to USD 8.00 Billion by 2034
globenewswire.com
PG
KMB
JNJ
UL
ABT
Form 8-K
sec.gov
JNJ
Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer
prnewswire.com
JNJ
LLY
Freehand Launches Freehand Pay, Expanding AI Teams from Invoice Audit to Payment
globenewswire.com
META
JNJ
PFE
CAH
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026
businesswire.com
JNJ
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
businesswire.com
JNJ
Global Precision Medical Devices Market Size, Share, Trends, and Forecast, 2026-2036 | AI, Robotics, and Connected Care Drive a $98.4 Billion Opportunity at 6.2% CAGR
globenewswire.com
MDT
GEHC
ABT
BSX
ISRG
JNJ
BDX
ZBH
RMD
MASI
Cerebrospinal Fluid (CSF) Management Market Size, Share, and Trends Analysis - Global Forecast, 2026-2036 | Market to Reach $3.28 Billion as Smart Shunts and Asia Pacific Growth Drive 5.5% CAGR
globenewswire.com
MDT
IART
JNJ
NTRA
ICUI
PEN
TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease
prnewswire.com
JNJ